[go: up one dir, main page]

FR3009504B1 - Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale - Google Patents

Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale

Info

Publication number
FR3009504B1
FR3009504B1 FR1301923A FR1301923A FR3009504B1 FR 3009504 B1 FR3009504 B1 FR 3009504B1 FR 1301923 A FR1301923 A FR 1301923A FR 1301923 A FR1301923 A FR 1301923A FR 3009504 B1 FR3009504 B1 FR 3009504B1
Authority
FR
France
Prior art keywords
cyclodextrins
self
oral administration
emulsionating
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1301923A
Other languages
English (en)
Other versions
FR3009504A1 (fr
Inventor
Mohamed Skiba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Skiba Mohamed Fr
Original Assignee
IN CYCLO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IN CYCLO filed Critical IN CYCLO
Priority to FR1301923A priority Critical patent/FR3009504B1/fr
Priority to PCT/FR2014/000182 priority patent/WO2015022454A1/fr
Priority to EP14758594.7A priority patent/EP3033110A1/fr
Publication of FR3009504A1 publication Critical patent/FR3009504A1/fr
Application granted granted Critical
Publication of FR3009504B1 publication Critical patent/FR3009504B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a pour objet un nouveau système sous forme de poudre instantané auto-émulsionnant, leur procédé de préparation ainsi que l'application de ce système huileux associe à une ou un mélange de cyclodextrines pour la formation instantané d'un système sphérique solide de types granules ou pellets effervescents ou non auto-émulsionnant (Spontaneous Powder Self Emulsifying Drug Delivery Systems (SP-SEDDS®)) . Et pour l'encapsulation de substance d'intérêt thérapeutique Applications à l'encapsulation d'une ou plusieurs substances d'intérêt notamment thérapeutique ou préventif, nutritionnel, et utilisables en pharmacie, vétérinaire, nutrition ou agroalimentaire par la voie orale.
FR1301923A 2013-08-12 2013-08-12 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale Active FR3009504B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1301923A FR3009504B1 (fr) 2013-08-12 2013-08-12 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale
PCT/FR2014/000182 WO2015022454A1 (fr) 2013-08-12 2014-08-05 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile (s) pour l'administration orale
EP14758594.7A EP3033110A1 (fr) 2013-08-12 2014-08-05 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile (s) pour l'administration orale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1301923A FR3009504B1 (fr) 2013-08-12 2013-08-12 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale

Publications (2)

Publication Number Publication Date
FR3009504A1 FR3009504A1 (fr) 2015-02-13
FR3009504B1 true FR3009504B1 (fr) 2025-10-24

Family

ID=50097717

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1301923A Active FR3009504B1 (fr) 2013-08-12 2013-08-12 Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale

Country Status (3)

Country Link
EP (1) EP3033110A1 (fr)
FR (1) FR3009504B1 (fr)
WO (1) WO2015022454A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660283B2 (en) 2018-12-19 2023-05-30 Joyn Botanicals Ltd. Cannabinoid-containing composition
CN111468050A (zh) * 2020-04-29 2020-07-31 福州大学 一种基于微流控技术制备复合精油微粒的方法
CN114081868B (zh) * 2021-10-20 2023-08-22 江苏大学 静电喷雾法制备的香叶木素固体自微乳纳米粒及制备方法
CN114847407B (zh) * 2022-06-16 2024-01-26 上海美农生物科技股份有限公司 一种缓控释型植物精油及其制备方法和应用
CN115350100A (zh) * 2022-07-08 2022-11-18 横琴孔雀大讲堂教育科技有限公司 一种包裹生物活性组分的水凝胶微胶囊及其制备方法和在化妆品中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850040B1 (fr) * 2003-01-20 2005-03-11 Centre Nat Rech Scient Systemes pour microencapsulation et leurs applications
FR2898817B1 (fr) * 2006-03-23 2008-08-08 Univ Rouen Association de substance oleagineuse avec un melange d'au moins deux cyclodextrines

Also Published As

Publication number Publication date
FR3009504A1 (fr) 2015-02-13
WO2015022454A1 (fr) 2015-02-19
EP3033110A1 (fr) 2016-06-22

Similar Documents

Publication Publication Date Title
Schmitz et al. “Disease modifying nutricals” for multiple sclerosis
FR3009504B1 (fr) Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile pour l'administration orale
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
PH12019500061A1 (en) Oral gastroretentive formulations and uses thereof
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
CL2018000705A1 (es) Método de cristalización y biodisponibilidad
EA201101706A1 (ru) Лекарственное средство на основе дииндолилметана(dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека
PH12020550815A1 (en) Delayed release deferiprone tablets and methods of using the same
EA201590797A1 (ru) Препараты с модифицированным высвобождением опрозомиба
EA200701923A1 (ru) Лекарственная форма для перорального введения витамина
Idkaidek Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems
PH12017501769A1 (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
BRPI0518789A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete
BR112017022335A2 (pt) combinação de dose fixa inviolável que fornece rápida liberação de dois fármacos a partir de partículas e matriz
BR112017022856A2 (pt) combinação de dose fixa inviolável que proporciona rápida liberação de duas drogas a partir de partículas
FI20155779A7 (fi) Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
PH12016502540B1 (en) Pharmaceutical dosage forms
WO2008024753A3 (fr) Nanoparticules dérivées de lipide pour administration de médicament dans le cerveau
Wankhade et al. Self microemulsifying nutraceutical and drug delivery systems
EA201492291A1 (ru) Амидофеноксипропаноламины
EA201792159A1 (ru) Способ получения сухих порошкообразных смесей
MX386932B (es) Proceso para formulaciones sólidas de mesalazina.
UA111462C2 (uk) Застосування (s)-2,6-діаміногексанової кислоти 3-метил-1,2,4-триазоліл-5-тіоацетату як активної основи лікарських засобів для профілактики та лікування порушень життєзабезпечуючих функцій цнс при важких формах гострого отруєння етанолом
MX389381B (es) Composición sólida con un inhibidor de la cox 2.
Badiu Amoxicillin/clavulanic acid/ciprofloxacin/diclofenac/ketoprofen

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

TP Transmission of property

Owner name: SKIBA, MOHAMED, FR

Effective date: 20171124

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 13